Sanorin Emulsion 0.1% Vial 10ml with Eucalyptus Oil

Packaging

Bottle of 10 ml.

Mechanism of action

Sanorin - a vasoconstrictor drug for local use in ENT practice. Alpha2 adrenomimetic. When applied topically, it has a rapid, pronounced and prolonged vasoconstrictor effect on the vessels of the mucous membrane (reduces swelling, hyperemia, exudation). Relieves nasal breathing in rhinitis and reduces swelling in conjunctivitis. After 5-7 days, tolerance arises.

Indications and usage

Acute rhinitis, sinusitis, laryngitis, eustachitis, rhinoscopy, the need to stop nasal bleeding; as an additional agent in the treatment of conjunctivitis of bacterial origin (for nasal drops of 0.05%).

Contraindications

Hypersensitivity to the components of the drug, chronic rhinitis, arterial hypertension, enlarged thyroid gland, tachycardia, marked atherosclerosis, glaucoma, diabetes mellitus, simultaneous administration of MAO inhibitors and a period of up to 14 days after the end of their use; children's age up to 15 years.

Dosage and administration

With acute rhinitis, sinusitis, eustachitis, laryngitis, to facilitate rhinoscopy adults and adolescents over 15 years old - 1-3 drops of nasal drops of 0.1% or 1-3 doses of spray in each nasal passage 3-4 times a day; nasal drops of 0.1% in the form of an emulsion prescribed 1-3 drops in each nasal passage 2-3 times a day.

Adverse Effects

Nausea, headache, increased blood pressure, tachycardia. Reactive hyperemia, swelling of the mucous membrane of the nasal cavity; when applied for more than 1 week - irritation, in some cases - swelling of the nasal mucosa.

Special notes

With prolonged use, the severity of the vasoconstrictive action gradually decreases (the phenomenon of tachyphylaxis), and therefore it is recommended to take a break for several days after 5-7 days of use in adults and after 3 days of use in children.

Drug Interactions

Simultaneous administration with MAO inhibitors and a period of up to 14 days after the end of their use increases the risk of severe arterial hypertension (release of deposited catecholamines under the action of naphazoline). Slows down absorption of local anesthetics.

In the dark place at a temperature of no higher than 25 ° C.